gplb_10k.htm

0001654954-22-003076.txt : 20220314 0001654954-22-003076.hdr.sgml : 20220314 20220314111053 ACCESSION NUMBER: 0001654954-22-003076 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 36 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Green Planet Bio Engineering Co. Ltd. CENTRAL INDEX KEY: 0001392449 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 371532842 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52622 FILM NUMBER: 22735572 BUSINESS ADDRESS: STREET 1: 20807 BISCAYNE BLVD. STREET 2: SUITE 203 CITY: AVENTURA STATE: FL ZIP: 33180 BUSINESS PHONE: 786-279-2900 MAIL ADDRESS: STREET 1: 20807 BISCAYNE BLVD. STREET 2: SUITE 203 CITY: AVENTURA STATE: FL ZIP: 33180 FORMER COMPANY: FORMER CONFORMED NAME: Mondo Acquisition II, Inc. DATE OF NAME CHANGE: 20070308 10-K 1 gplb_10k.htm FORM 10-K gplb_10k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

_______________________

FORM 10-K

_______________________

(Mark One)

☒	Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	For the Fiscal Year Ended December 31, 2021

☐	Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

	For the transition period from to

Commission file number 000-52622

GREEN PLANET BIOENGINEERING CO., LTD.

(Exact Name of Registrant as Specified in its charter)

Delaware		37-1532842
(State or Other Jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification No.)

20807 Biscayne Blvd., Suite 203, Aventura, Florida		33180
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (786) 279-2900

Securities registered pursuant to Section 12(b) of the Act: NONE

Securities registered pursuant to Section 12(g) of the Act: NONE

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ☐ No ☒

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☒ No ☐

The aggregate market value of the registrant’s common stock held by non-affiliates was $65,655 based on the closing sale price of common stock on June 30, 2021. The number of shares of common stock outstanding as of March 14, 2022 was 20,006,402.

TABLE OF CONTENTS

PART I

Item 1.	Business	4
Item 1A.	Risk Factors	4
Item 1B.	Unresolved Staff Comments	5
Item 2.	Properties	5
Item 3.	Legal Proceedings	5
Item 4.	Mine Safety Disclosures	5

PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	6
Item 6.	Selected Financial Data	6
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	6
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	7
Item 8.	Financial Statements	7
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	16
Item 9A.	Controls and Procedures	16
Item 9B.	Other Information	16

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	17
Item 11.	Executive Compensation	17
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	18
Item 13.	Certain Relationships and Related Transactions, and Director Independence	18
Item 14.	Principal Accounting Fees and Services	18

PART IV

Item 15.	Exhibits and Financial Statement Schedules	19

Signatures		20

Table of Contents

FORWARD-LOOKING STATEMENTS

This Annual Report on Form 10-K contains forward-looking statements. These statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses. Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes,” “may,” “will,” “should,” “could,” “plans,” “estimates,” and similar language or negative of such terms. Our actual results may differ significantly from those projected in the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we do not know whether we can achieve positive future results, levels of activity, performance, or goals. Actual events or results may differ materially. We undertake no obligation to publicly release any revisions to the forward-looking statements or reflect events or circumstances taking place after the date of this document.

Table of Contents

PART I

ITEM 1. BUSINESS

Description of Business

Green Planet Bioengineering Co., Ltd. (“Green Planet” or “Company”) operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation.

Our History

Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name to Green Planet Bioengineering Co., Ltd. on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, a company incorporated in British Virgin Islands, and its subsidiaries (“Elevated Throne”) which operated the business in the agritech sector in the People’s Republic of China. The Company divested Elevated Throne to One Bio, Corp. (“ONE”) on April 14, 2010.

In March 2012, Global Funds Holdings Corp. (“Global Funds”) an Ontario, Canada corporation became a majority stockholder of the Company.

The Company operates as a public organized shell corporation with the purpose to acquire or merge with an existing business operation. The Company’s activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

ITEM 1A. RISK FACTORS

You should consider carefully each of the following business and investment risk factors and all of the other information in this report. If any of the following risks and uncertainties develops into actual events, the business, financial condition or results of our operations could be materially and adversely affected. If that happens, the trading price of our shares of common stock could decline significantly. The risk factors below contain forward-looking statements regarding our business. Actual results could differ materially from those set forth in the forward-looking statements. See “Special Note Regarding Forward-Looking Information.”

Risk Related to the Covid-19 pandemic

The Company’s operation has not been materially and adversely impacted by the Covid-19 pandemic. While the Company is able to continue operations as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation that can operate with staff at the office as long as they maintain social distancing. The Company is unable to predict the impact of the Covid-19 pandemic at this time.

Risk Related to the Company’s Future Business

We give no assurances that any plans for future business will be implemented if we do not secure adequate financing or find profitable business opportunities.

Our ability to implement and execute our future business plans and ultimately generate enough business revenue is directly influenced by our ability to secure adequate financing or find profitable business opportunities. If we do not receive funding from future investors or find profitable business opportunities, we will experience delays in our business plans and, ultimately, in our profitability going forward.

We will continue to incur significant costs as a result of remaining as a public reorganized company, and management will be required to devote substantial time to new compliance requirements.

As a public company, we incur significant legal, accounting and other expenses under the Sarbanes-Oxley Act of 2002, together with rules implemented by the Securities and Exchange Commission and applicable market regulators. These rules impose various requirements on public companies, including requiring certain corporate governance practices. Management and other personnel will need to devote a substantial amount of time to these new compliance requirements. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time consuming and costlier.

Table of Contents

In addition, the Sarbanes-Oxley Act requires, among other things, that we maintain effective internal controls for financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluations and testing of our internal controls over financial reporting to allow management and our registered independent public accounting firm to report on the effectiveness of our internal controls over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act. Our testing, or the subsequent testing by our registered independent public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses. Compliance with Section 404 may require that we incur substantial accounting expenses and expend significant management efforts. If we are not able to comply with the requirements of Section 404 in a timely manner, or if our registered independent accountants later identify deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to sanctions or investigations by the SEC or other applicable regulatory authorities.

Risks Related to the Common Stock

There is currently no trading market for our common stock.

Outstanding shares of our common stock cannot be offered, sold, pledged or otherwise transferred unless subsequently registered pursuant to, or exempt from registration under, the Securities Act and any other applicable federal or state securities laws or regulations. These restrictions will limit the ability of our stockholders to liquidate their investment.

We have not paid and do not anticipate paying any dividends on our common stock; therefore, our securities could face devaluation in the market.

We have paid no dividends on our common stock to date and it is not anticipated that any dividends will be paid to holders of our common stock in the foreseeable future. While our dividend policy will be based on the operating results and capital needs of the business, it is anticipated that any earnings will be retained to finance our future expansion and for the implementation of our new business plan. Lack of a dividend can further affect the market value of our common stock, and could significantly affect the value of any investment in us.

Penny Stock Regulations

The SEC has adopted regulations which generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share. Our common stock, when and if a trading market develops, may fall within the definition of penny stock and subject to rules that impose additional sales practice requirements on broker-dealers.

For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s prior written consent to the transaction. Additionally, for any transaction, other than exempt transactions, involving a penny stock, the rules require the delivery, prior to the transaction, of a risk disclosure document mandated by the Securities and Exchange Commission relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. Consequently, the “penny stock” rules may restrict the ability of broker-dealers to sell our common stock and may affect the ability of investors to sell their common stock in the secondary market.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None

ITEM 2. PROPERTIES

None

ITEM 3. LEGAL PROCEEDINGS

None

ITEM 4. MINE SAFETY DISCLOSURES

None

Table of Contents

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

The Company’s common stock is available for quotation on the Over the Counter Bulletin Board under the symbol “GPLB.PK.” There is no assurance that the company’s stock will continue to be quoted or that any liquidity will exist for our stockholders.

The following table shows, for each quarter of fiscal 2021 and 2020 the high and low closing price per share of common stock as reported on the Over the Counter Bulletin Board. The following quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not represent actual transactions. The source of this information is NASDAQ Over the Counter Bulletin Board Research Report.

	2021				2020
Quarter Ended	High		Low		High		Low

Fourth Quarter	$	0.390	$	0.150	$	0.060	$	0.041
Third Quarter		0.250		0.060		0.118		0.050
Second Quarter		0.110		0.050		0.118		0.040
First Quarter		0.190		0.040		0.080		0.040

We have never declared or paid any cash dividends on our common stock.

ITEM 6. SELECTED FINANCIAL DATA

Not applicable.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation.

Results of Operations

The Company did not have any operations and did not have any operating revenues during the years ended December 31, 2021 and 2020, respectively.

Total expenses for the for the years ended December 31, 2021 and 2020 were $32,929 and $33,599, respectively. The majority of these expenses primarily constituted administrative expenses related to accounting and compliance with the Exchange Act.

Liquidity and Capital Resources

The Company had no active business operation during the year. Accordingly, all the Company’s cash flow needs for 2021 were provided solely by a related party of Global Funds to pay expenses necessary as a public company.

Going forward, the Company will continue to source adequate funding from future investors to execute business opportunities when they arise in the future. However, such funding and business opportunities will rely entirely on the prevailing circumstances when the funding or profitable business opportunities are identified. If such opportunities are not identified in the near term, the Company will experience delay in effecting its business plans.

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from Global Funds, the majority stockholder. This gives rise to substantial doubt about the Company’s ability to continue as a going concern.

Table of Contents

Critical Accounting Policies and Estimates

We prepare our financial statements in conformity with accounting principles generally accepted (“GAAP”) in the United States of America. As such, we are required to make certain estimates, judgments and assumptions that we believe are reasonable based upon historical experience, current trends and other factors. As such, actual results could differ from our estimates and such differences could be material. We have identified below the critical accounting policies which are assumptions made by management about matters that are uncertain and are of critical importance in the presentation of our financial position, results of operations and cash flows. On a regular basis, we review our accounting policies and how they are applied and disclosed in the financial statements.

The preparation of financial statements in conformity with GAAP in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

None

ITEM 8. FINANCIAL STATEMENTS

INDEX TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firms (PCAOB Firm ID: 287)		8
Financial Statements:
Balance Sheets		9
Statements of Operations		10
Statements of Cash Flows		11
Statements of Changes in Stockholders’ Deficit		12
Notes to the Financial Statements		13-15

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

Green Planet Bioengineering Co., Ltd.

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Green Planet Bioengineering Co., Ltd. (the Company) as of December 31, 2021 and 2020, and the related statements of operations, stockholders' deficit, and cash flows for each of the years in the two-year period ended December 31, 2021, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

Going concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company is currently a public reorganized shell corporation and has no current business activity. The Company's ability to continue as a going concern is dependent on continued support from a related party. These factors raise substantial doubt about the Company's ability to continue as a going concern. Management's plans concerning these matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit matters.

/s/ Liggett & Webb, P.A.

We have served as the Company's auditor since 2019.

Boynton Beach, Florida

March 14, 2022

Table of Contents

Green Planet Bioengineering Co., Ltd

Balance Sheets

(Stated in US Dollars)

	December 31,			December 31,
	2021			2020
ASSETS
Current assets
Cash and cash equivalents	$	-		$	-

TOTAL CURRENT ASSETS	$	-		$	-

LIABILITIES AND STOCKHOLDERS’ DEFICIT

LIABILITIES
Current liabilities
Amount due to a related party	$	349,387		$	316,458

TOTAL CURRENT LIABILITIES		349,387			316,458

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS’ DEFICIT
Preferred stock: par value of $0.001 per share
Authorized: 10,000,000 shares at December 31, 2021 and December 31, 2020
Issued and outstanding:
None at December 31, 2021 and December 31, 2020		-			-

Common stock: par value of $0.001 per share
Authorized: 250,000,000 shares at December 31, 2021 and December 31, 2020
Issued and outstanding: 20,006,402 shares at December 31, 2021 and December 31, 2020		20,006			20,006
Additional paid-in-capital		609,614			609,614
Accumulated deficit		(979,007	)		(946,078	)

TOTAL STOCKHOLDERS’ DEFICIT		(349,387	)		(316,458	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	-		$	-

See Notes to the Financial Statements

Table of Contents

Green Planet Bioengineering Co., Ltd

Statements of Operations

(Stated in US Dollars)

	Years ended December 31,
	2021			2020
Administrative expenses	$	(32,929	)	$	(33,599	)

Loss before income tax		(32,929	)		(33,599	)
Provision for income taxes		-			-

Net loss	$	(32,929	)	$	(33,599	)

Loss per share
-Basic and diluted	$	(*	)	$	(*	)

Weighted average number of shares outstanding
-Basic and diluted		20,006,402			20,006,402

Less than $.01, per share

See Notes to the Financial Statements

Table of Contents

Green Planet Bioengineering Co., Ltd

Statements of Cash Flows

(Stated in US Dollars)

	Years ended December 31,
	2021			2022
Cash flows from operating activities
Net loss	$	(32,929	)	$	(33,599	)
Changes in operating assets and liabilities:
Accounts payable		-			(214	)

Net cash flows used in operating activities		(32,929	)		(33,813	)


Cash flows from financing activities
Amount due to a related party		32,929			33,813

Net cash flows provided by financing activities		32,929			33,813

Net decrease in cash and cash equivalents		-			-

Cash and cash equivalents – beginning of year		-			-

Cash and cash equivalents – end of year	$	-		$	-

Supplemental disclosures for cash flow information:
Cash paid for interest	$	-		$	-

Cash paid for income taxes	$	-		$	-

See Notes to the Financial Statements

Table of Contents

Green Planet Bioengineering Co., Ltd

Statements of Changes in Stockholders’ Deficit

(Stated in US Dollars)

	Preferred Stock				Common Stock				Additional paid-in		Accumulated
	Number of shares		Amount		Number of shares		Amount		capital		deficit			Total
Balance, December 31, 2019		-	$	-		20,006,402	$	20,006	$	609,614	$	(912,479	)	$	(282,859	)

Net loss		-		-		-		-		-		(33,599	)		(33,599	)

Balance, December 31, 2020		-	$	-		20,006,402	$	20,006	$	609,614	$	(946,078	)	$	(316,458	)

Net Loss		-		-		-		-		-		(32,929	)		(32,929	)

Balance, December 31, 2021		-	$	-		20,006,402	$	20,006	$	609,614	$	(979,007	)	$	(349,387	)

See Notes to the Financial Statements

Table of Contents

Green Planet Bioengineering Co., Ltd.

Notes to the Financial Statements

1. General Information

Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and the name was changed to Green Planet Bioengineering Co., Ltd. (“Company”) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries (“Elevated Throne”) and operated the business in the agritech sector in the People’s Republic of China. The Company divested Elevated Throne to One Bio, Corp. (“ONE”) on April 14, 2010.

In March 2012, Global Funds Holdings Corp. (“Global Funds”) an Ontario, Canada corporation became a majority stockholder of the Company.

The Company operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation. The Company’s activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

2. Summary of Significant Accounting Policies

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported. Actual results could differ from those estimates. Significant items that require estimates were accruals of liabilities.

Cash and Cash Equivalents

Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.

Income Taxes

The Company accounts for income taxes in accordance with FASB ASC Topic 740 “Income Taxes” under which deferred tax assets and liabilities are determined based on temporary differences between accounting and tax bases of assets and liabilities and net operating loss and credit carry forwards, using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. A provision for income tax expense is recognized for income taxes payable for the current period, plus the net changes in deferred tax amounts. Any interest and penalties are expensed in the year that the Notice of Assessment is received. The Company’s practice is to recognize interest and/or penalties related to income tax matters as interest expense.

Loss Per Share

Earnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures. Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive. Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share. As of December 31, 2021 and 2020 the Company does not have any common share equivalents outstanding.

Table of Contents

2. Summary of Significant Accounting Policies – continued

Fair Value Measurements

FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investments measured and reported at fair value are classified and disclosed in one of the following hierarchy:

Level 1 -	Quoted prices are available in active markets for identical investments as of the period reporting date.

Level 2 -	Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

Level 3 -	Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.

Recent Changes in Accounting Standards

In June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including the interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The adoption of this ASU did not have a material impact on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

3. Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from a related party. This gives rise to substantial doubt about the Company’s ability to continue as a going concern.

4. Amount Due to a Related party

The Company relies on a related party to advance funds to fund its operating expenses. As of December 31, 2021 and 2020, the amounts advanced of $349,387 and $316,458 respectively are interest-free, unsecured and are repayable upon demand.

In addition, the Chief Executive Officer, Chief Financial Officer and Director of the Company is also a director of the related party.

5. Preferred Stock/Common Stock

Series A preferred stock

The Company is authorized under its Articles of Incorporation to issue 10,000,000 shares of Series A preferred stock with a par value of $0.001 per share. Each share of the Company’s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company’s common stock. The preferred stock is non-participating and carries no dividend. The Company does not have any issued shares of the preferred stock as of December 31, 2021 and 2020.

Common Stock

The Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001 per share. During the year ended December 31, 2021 and 2020, the Company did not issue any shares of common stock or warrants.

Table of Contents

6. Income Tax

As of December 31, 2021, the Company had net operating loss carry forwards of approximately $943,000 that may be available to reduce future years’ taxable income through 2037. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards. The deferred tax asset and valuation allowance were reduced by approximately $1,000 to reflect the change in the federal tax rate from 34% to 21%.

The provision for Federal income tax consists of the following for the years ended December 31, 2021 and December 31, 2020:

	December 31, 2021			December 31, 2020
Federal income tax benefit attributable to:
Net loss	$	(7,000	)	$	(8,500	)
Change in tax estimates		-			10,000
Less: valuation allowance		7,000			1,700

Net provision for Federal income taxes	$	-		$	-

The cumulative tax effect at the expected rate of 21% for 2021 and 21% for 2020 of significant items comprising our net deferred tax amount is as follows as of December 31, 2021 and December 31, 2020:

	December 31, 2021			December 31, 2020
Deferred tax asset attributable to:
Net operating loss carryover	$	238,000		$	231,000
Less: valuation allowance		(238,000	)		(231,000	)

Net deferred tax asset	$	-		$	-

Due to the change in ownership in March 2012, the net operating loss carry forwards as of December 31, 2011 of $213,844 may be subject to limitations in accordance with Sec 382 of the provisions of the Tax Reform Act of 1986 for Federal income tax purposes. Tax return for the years ended December 31, 2021, 2020 and 2019 remain open to and it by Federal and State Tax Authorities.

Table of Contents

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Control and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in company reports filed or submitted under the Securities Exchange Act of 1934, or the “Exchange Act,” is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our chief executive officer as appropriate to allow timely decisions regarding disclosure.

The Company’s management, with the participation of the Company’s President and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of the financial year end. Based upon their evaluation, the Company’s President and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective and did not note any material weakness.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate “internal control over financial reporting” as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:

	i.	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

	ii.	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

	iii.	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

As of December 31, 2021, and as reported in the Registrant’s Form 10-K filing, management used the framework set forth in the report entitled “Internal Control – Integrated Framework” published by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of our internal control over financial reporting. Based on its evaluation, management concluded that at December 31, 2021 there were no material weakness and concluded that the internal control over financial reporting was effective. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

During the year, there has been no change in our internal control over financial reporting that has materially affected or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None

Table of Contents

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Generally, each of our directors is elected to a term of one year and serves until his or her successor is elected and qualified. The Directors and Officers of the Company are as follows:

Name		Age				Position		Term
Jordan Weingarten			32			President and Director		March 2012 to present

Mr. Weingarten graduated from York University with a degree in business administration. He is an executive with experience in financial controls, finance and global management. Amongst other assignments, Mr. Weingarten was financial control specialist at Trade Finance Solutions, Inc, a Canadian corporation, and was also involved in management at a global Polaroid Licensee. Mr. Weingarten also worked with international wholesalers and distributors of electronics and various other products. Based in Miami, Florida, Mr. Weingarten brings knowledge and experience of global economics, finances and cultural environment. The President & Director of Green Planet Bioengineering Co. Ltd. is also a Director of the Related Party.

All of our directors hold offices until the next annual meeting of the stockholders of the Company, and until their successors have been qualified after being elected or appointed. Officers serve at the discretion of the Board of Directors.

Director Compensation

We do not currently nor have we ever compensated our directors.

Involvement in Legal Proceedings

None of our executive officers or directors have been the subject of any order, judgment, or decree of any court of competent jurisdiction, or any regulatory agency permanently or temporarily enjoining, barring suspending or otherwise limiting him from acting as an investment advisor, underwriter, broker or dealer in the securities industry, or as an affiliated person, director or employee of an investment company, bank, savings and loan association, or insurance company, or from engaging in or continuing any conduct or practice in connection with any such activity or in connection with the purchase or sale of any securities.

None of our executive officers or directors has been convicted in any criminal proceeding (excluding traffic violations) or is the subject of a criminal proceeding that is currently pending.

None of our executive officers or directors is the subject of any material pending legal proceeding.

Audit Committee

The Company has not as of yet established an audit committee. The Board of Directors currently serves as the Company’s audit committee.

Compensation Committee

The Company has not as of yet established a compensation committee. The Board of Directors currently serves as the Company’s compensation committee.

Section 16 (A) Beneficial Ownership Reporting Compliance

Section 16 (A) of the Securities Exchange Act of 1934, as amended, requires the Company’s directors, executive officers and persons who own more than 10% of a class of the Company’s equity securities which are registered under the Exchange Act to file with the Securities and Exchange Commission initial reports of ownership and reports of changes of ownership of such registered securities. Such executive officers, directors and greater than 10% beneficial owners are required by Commission regulation to furnish the Company with copies of all Section 16 (A) forms filed by such reporting persons.

To the Company’s knowledge, based solely on a review of the copies of such reports furnished to the Company and on representations that no other reports were required, no person required to file such a report, failed to file during fiscal 2021 and 2020.

Code of Ethics

The Board of Directors adopted a Code of Ethics in April 2009, meeting the requirements of Section 406 of the Sarbanes-Oxley Act of 2002. The Company will provide to any person without charge, upon request, a copy of such Code of Ethics.

ITEM 11. EXECUTIVE COMPENSATION

The Company did not pay any compensation to its executive officers for the years ended December 31, 2011 to 2021.

Table of Contents

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

	Shares of Common Stock
	Beneficially Owned (1)
Name of Beneficial Owner	Number		% (2)
Global Funds Holdings Corp		18,508,733		92

(1)	Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to securities anticipated to be exercisable or convertible at or within 60 days of the date hereof, are deemed outstanding for computing the percentage of the person holding such option or warrant but are not deemed outstanding for computing the percentage of any other person. The indication herein that shares are anticipated to be beneficially owned is not an admission on the part of the listed stockholder that he, she or it is or will be a direct or indirect beneficial owner of those shares.

(2)	Based upon 20,006,402 shares of common stock issued and outstanding as of December 31, 2021.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Certain Relationships

None

Related Transactions

All related transactions have been reported in Part II Item 8 Financial Statements.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

Audit Fees

The aggregate fees billed for fiscal year ended December 31, 2021 and 2020 for professional services rendered by Liggett and Webb P.A. for the audit of the Company’s annual financial statements was $10,000 and $10,000 respectively.

The aggregate fees billed for fiscal year ended December 31, 2021 and 2020 for professional services rendered by Liggett and Webb P.A. for the reviews of the Company’s quarterly financial statements included in the Company’s Form 10-Q’s was $15,000 and $15,000 respectively.

Audit Related Fees

None

Tax Fees

Tax fees are those fees billed for professional services rendered for tax compliance, including preparation of corporate federal and state income tax returns, tax advice and tax planning. For the years ended December 31, 2021 and 2020, no tax fees were billed by Liggett & Webb, P.A.

All Other Fees

None

Policy for Pre-Approval of Audit and Non-Audit Services

We have not established an audit committee. Our board of directors approved the services rendered and fees charged by our independent registered public accounting firm.

Our board of directors’ policy is to pre-approve all audit services and all non-audit services that our independent registered public accounting firm is permitted to perform for us under applicable federal securities regulations. As permitted by the applicable regulations, our board of directors’ policy utilizes a combination of specific pre-approval on a case-by-case basis of individual engagements of the independent registered public accounting firm.

All engagements of the independent registered public accounting firm to perform any audit services and non-audit services since that date have been pre-approved by our board of directors in accordance with the pre-approval policy. The policy has not been waived in any instance. All engagements of the independent registered public accounting firm to perform any audit services and non-audit services prior to the date the pre-approval policy was implemented were approved by our board of directors in accordance with its normal functions.

Table of Contents

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)

Exhibits

	31.1		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	31.2		Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
	32		Certification pursuant to 18 U.S.C. Section 1350

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned; thereunto duly authorized this 14^thday of March, 2022.

	Green Planet Bioengineering Co., Ltd

	By:	/s/ Jordan Weingarten
		Jordan Weingarten President (Principal Executive Officer and Principal Financial and Accounting Officer) and Director

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Date: March 14, 2022	By:	/s/ Jordan Weingarten
		Jordan Weingarten
		President and Director

EX-31.1 2 gplb_ex311.htm CERTIFICATION gplb_ex311.htm

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jordan Weingarten, certify that:

1.	I have reviewed this Annual Report on Form 10-K of Green Planet Bioengineering Co., Ltd;

2.	Based on my knowledge, this Annual Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report;

3.	Based on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Annual Report;

4.	The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:

	a.	designed such disclosure controls and procedures, or have caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Annual Report is being prepared;

	b.	designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Annual Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the period covered by this report based on such evaluation; and

	d.	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting ; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

	a.	all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and

	b.	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

DATE: March 14, 2022	By:	/s/ Jordan Weingarten
		Jordan Weingarten
		President (Principal Executive Officer)

EX-31.2 3 gplb_ex312.htm CERTIFICATION gplb_ex312.htm

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jordan Weingarten, certify that:

1.	I have reviewed this Annual Report on Form 10-K of Green Planet Bioengineering Co., Ltd;

2.	Based on my knowledge, this Annual Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Annual Report;

3.	Based on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this Annual Report;

4.	The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:

	a.	designed such disclosure controls and procedures, or have caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Annual Report is being prepared;

	b.	designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this Annual Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the period covered by this report based on such evaluation; and

	d.	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting ; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

	a.	all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process summarize and report financial information; and

	b.	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

DATE:March 14, 2022

By:

Jordan Weingarten

Jordan Weingarten

Chief Financial

Officer (Principal Financial

and Accounting Officer)

EX-32 4 gplb_ex32.htm CERTIFICATION gplb_ex32.htm

EXHIBIT 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.

SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Green Planet Bioengineering Co., Ltd (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jordan Weingarten, President and Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and to the best of my knowledge and belief, that:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (16 U.S.C. 78m or 78o (d); and

	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

DATE: March 14, 2022

By:

/s/ Jordan Weingarten

Jordan Weingarten

President and Chief Financial Officer

(Principal Executive Officer and

Principal Financial and Accounting Officer)

EX-101.SCH 5 gplb-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Statements of Operations link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Statements of Changes in Stockholders' Deficit link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - 1. General Information link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - 2. Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - 3. Going Concern link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - 4. Amount Due to a Related Party link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - 5. Preferred Stock/Common Stock link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - 6. Income Tax link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - 2 Summary of significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - 6. Income Tax (Tables) link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - 1. General Information (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - 4. Amount Due to a Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - 5. Preferred Stock/Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - 6 Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - 6 Income Tax (Details 1) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - 6. Income Tax (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 gplb-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Voluntary Filers Current Fiscal Year End Date Entity Well Known Seasoned Issuer Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Entity Public Float Document Annual Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Interactive Data Current Entity Tax Identification Number Entity Address Postal Zip Code Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province City Area Code Local Phone Number Auditor Name Auditor Location Auditor Firm Id Balance Sheets ASSETS Current assets Cash and cash equivalents TOTAL CURRENT ASSETS [Assets, Current] LIABILITIES AND STOCKHOLDERS' DEFICIT LIABILITIES Current liabilities Amount due to a related party TOTAL CURRENT LIABILITIES [Liabilities, Current] COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' DEFICIT Preferred stock: par value of $0.001 per share Issued and outstanding:None at December 31, 2021 and December 31, 2020 Common stock: par value of $0.001 per share Issued and outstanding: 20,006,402 shares at December 31, 2021 and December 31, 2020 Additional paid-in-capital Accumulated (deficit) TOTAL STOCKHOLDERS' DEFICIT [Stockholders' Equity Attributable to Parent] TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT [Liabilities and Equity] STOCKHOLDERS' DEFICIT Preferred stock, par value Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Common stock, par value Common stock, authorized Common stock, issued Common stock, outstanding Statements of Operations Administrative expenses [General and Administrative Expense] Loss before income tax [Income (Loss) from Continuing Operations before Income Taxes, Domestic] Provision for income taxes Net loss [Net Income (Loss) Attributable to Parent] Loss per share -Basic and diluted Weighted average number of shares outstanding -Basic and diluted [Weighted Average Number of Shares Outstanding, Basic and Diluted] Statements of Changes in Stockholders' Deficit Statement [Table] Statement [Line Items] Statement Equity Components [Axis] Preferred Stock Common Stock Additional Paid-In Capital Retained Earnings (Accumulated Deficit) Balance, shares [Shares, Issued] Balance, amount Net loss Balance, shares Balance, amount Statements of Cash Flows Cash flows from operating activities Net loss Changes in operating assets and liabilities: Accounts payable Net cash flows used in operating activities [Net Cash Provided by (Used in) Operating Activities] Cash flows from financing activities Amount due to a related party [Increase (Decrease) in Due to Related Parties] Net cash flows provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net decrease in cash and cash equivalents [Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] Cash and cash equivalents - beginning of year Cash and cash equivalents - end of year Supplemental disclosures for cash flow information: Cash paid for interest Cash paid for Income taxes 1. General Information 1. General Information Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] 2. Summary of Significant Accounting Policies 2. Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] 3. Going Concern Substantial Doubt about Going Concern [Text Block] 4. Amount Due to a Related Party 4. Amount Due to a Related Party Related Party Transactions Disclosure [Text Block] 5. Preferred Stock/Common Stock 5. Preferred Stock/Common Stock Stockholders' Equity Note Disclosure [Text Block] 6. Income Tax 6. Income Tax Income Tax Disclosure [Text Block] Basis of Presentation Use of Estimates Cash and Cash Equivalents Income Taxes Loss Per Share Fair Value Measurements Recent Changes in Accounting Standards Provision for income taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Deferred tax assets Incorporation date Amount due to a related party Preferred stock, par value Preferred stock, authorized Common stock, par value Common stock, authorized Voting rights shares Preferred stock convertible into shares Federal income tax benefit attributable to: Net loss [Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount] Change in tax estimates Less: valuation allowance Net provision for Federal income taxes Deferred tax asset attributable to: Net operating loss carryforwards Less: valuation allowance [Deferred Tax Assets, Valuation Allowance] Net deferred tax asset Net operating loss carry forwards Description of asset and allowances Cumulative tax effect rate EX-101.CAL 7 gplb-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 gplb-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 gplb-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT

Cover - USD ($)	12 Months Ended
Cover - USD ($)	Dec. 31, 2021	Mar. 14, 2022	Jun. 30, 2021
Cover [Abstract]
Entity Registrant Name	GREEN PLANET BIOENGINEERING CO., LTD.
Entity Central Index Key	0001392449
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		20,006,402
Entity Public Float			$ 65,655
Document Annual Report	true
Document Transition Report	false
Entity File Number	000-52622
Entity Incorporation State Country Code	DE
Entity Interactive Data Current	Yes
Entity Tax Identification Number	37-1532842
Entity Address Postal Zip Code	33180
Entity Address Address Line 1	20807 Biscayne Blvd.
Entity Address Address Line 2	Suite 203
Entity Address City Or Town	Aventura
Entity Address State Or Province	FL
City Area Code	786
Local Phone Number	279-2900
Auditor Name	Liggett & Webb, P.A.
Auditor Location	Boynton Beach, Florida
Auditor Firm Id	287

XML 11 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 0	$ 0
TOTAL CURRENT ASSETS	0	0
Current liabilities
Amount due to a related party	349,387	316,458
TOTAL CURRENT LIABILITIES	349,387	316,458
STOCKHOLDERS' DEFICIT
Preferred stock: par value of $0.001 per share Issued and outstanding:None at December 31, 2021 and December 31, 2020	0	0
Common stock: par value of $0.001 per share Issued and outstanding: 20,006,402 shares at December 31, 2021 and December 31, 2020	20,006	20,006
Additional paid-in-capital	609,614	609,614
Accumulated (deficit)	(979,007)	(946,078)
TOTAL STOCKHOLDERS' DEFICIT	(349,387)	(316,458)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 0	$ 0

XML 12 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	10,000,000	10,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	250,000,000	250,000,000
Common stock, issued	20,006,402	20,006,402
Common stock, outstanding	20,006,402	20,006,402

XML 13 R4.htm IDEA: XBRL DOCUMENT

Statements of Operations - USD ($)	12 Months Ended
Statements of Operations - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Statements of Operations
Administrative expenses	$ (32,929)	$ (33,599)
Loss before income tax	(32,929)	(33,599)
Provision for income taxes	0	0
Net loss	$ (32,929)	$ (33,599)
Loss per share
-Basic and diluted	$ (0.00)	$ (0.00)
Weighted average number of shares outstanding
-Basic and diluted	20,006,402	20,006,402

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599

+ Details

XML 14 R5.htm IDEA: XBRL DOCUMENT

Statements of Changes in Stockholders' Deficit - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2019			20,006,402
Balance, amount at Dec. 31, 2019	$ (282,859)	$ 0	$ 20,006	$ 609,614	$ (912,479)
Net loss	(33,599)	0	$ 0	0	(33,599)
Balance, shares at Dec. 31, 2020			20,006,402
Balance, amount at Dec. 31, 2020	(316,458)	0	$ 20,006	609,614	(946,078)
Net loss	(32,929)	0	$ 0	0	(32,929)
Balance, shares at Dec. 31, 2021			20,006,402
Balance, amount at Dec. 31, 2021	$ (349,387)	$ 0	$ 20,006	$ 609,614	$ (979,007)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 15 R6.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows - USD ($)	12 Months Ended
Statements of Cash Flows - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net loss	$ (33,599)	$ (32,929)
Changes in operating assets and liabilities:
Accounts payable	(214)	0
Net cash flows used in operating activities	(33,813)	(32,929)
Cash flows from financing activities
Amount due to a related party	33,813	32,929
Net cash flows provided by financing activities	33,813	32,929
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents - beginning of year	0	0
Cash and cash equivalents - end of year	0	0
Supplemental disclosures for cash flow information:
Cash paid for interest	0	0
Cash paid for Income taxes	$ 0	$ 0

XML 16 R7.htm IDEA: XBRL DOCUMENT

1. General Information

12 Months Ended

Dec. 31, 2021

1. General Information

1. General Information

1. General Information

In March 2012, Global Funds Holdings Corp. (“Global Funds”) an Ontario, Canada corporation became a majority stockholder of the Company.

XML 17 R8.htm IDEA: XBRL DOCUMENT

2. Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2021

2. Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

Use of Estimates

Cash and Cash Equivalents

Income Taxes

Loss Per Share

Fair Value Measurements

Level 1 -	Quoted prices are available in active markets for identical investments as of the period reporting date.

Level 2 -	Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

Level 3 -	Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.

Recent Changes in Accounting Standards

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

XML 18 R9.htm IDEA: XBRL DOCUMENT

3. Going Concern

12 Months Ended

Dec. 31, 2021

1. General Information

3. Going Concern

3. Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from a related party. This gives rise to substantial doubt about the Company’s ability to continue as a going concern.

XML 19 R10.htm IDEA: XBRL DOCUMENT

4. Amount Due to a Related Party

12 Months Ended

Dec. 31, 2021

4. Amount Due to a Related Party

4. Amount Due to a Related Party

4. Amount Due to a Related party

In addition, the Chief Executive Officer, Chief Financial Officer and Director of the Company is also a director of the related party.

XML 20 R11.htm IDEA: XBRL DOCUMENT

5. Preferred Stock/Common Stock

12 Months Ended

Dec. 31, 2021

5. Preferred Stock/Common Stock

5. Preferred Stock/Common Stock

5. Preferred Stock/Common Stock

Series A preferred stock

Common Stock

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 21 R12.htm IDEA: XBRL DOCUMENT

6. Income Tax

12 Months Ended

Dec. 31, 2021

6. Income Tax

6. Income Tax

6. Income Tax

The provision for Federal income tax consists of the following for the years ended December 31, 2021 and December 31, 2020:

	December 31, 2021			December 31, 2020
Federal income tax benefit attributable to:
Net loss	$	(7,000	)	$	(8,500	)
Change in tax estimates		-			10,000
Less: valuation allowance		7,000			1,700

Net provision for Federal income taxes	$	-		$	-

	December 31, 2021			December 31, 2020
Deferred tax asset attributable to:
Net operating loss carryover	$	238,000		$	231,000
Less: valuation allowance		(238,000	)		(231,000	)

Net deferred tax asset	$	-		$	-

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 22 R13.htm IDEA: XBRL DOCUMENT

2 Summary of significant accounting policies (Policies)

12 Months Ended

Dec. 31, 2021

2. Summary of Significant Accounting Policies

Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

Use of Estimates

Cash and Cash Equivalents

Income Taxes

Loss Per Share

Fair Value Measurements

Level 1 -	Quoted prices are available in active markets for identical investments as of the period reporting date.

Level 2 -	Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

Level 3 -	Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.

Recent Changes in Accounting Standards

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References + Details

XML 23 R14.htm IDEA: XBRL DOCUMENT

6. Income Tax (Tables)

12 Months Ended

Dec. 31, 2021

6. Income Tax

Provision for income taxes

	December 31, 2021			December 31, 2020
Federal income tax benefit attributable to:
Net loss	$	(7,000	)	$	(8,500	)
Change in tax estimates		-			10,000
Less: valuation allowance		7,000			1,700

Net provision for Federal income taxes	$	-		$	-

Deferred tax assets

	December 31, 2021			December 31, 2020
Deferred tax asset attributable to:
Net operating loss carryover	$	238,000		$	231,000
Less: valuation allowance		(238,000	)		(231,000	)

Net deferred tax asset	$	-		$	-

XML 24 R15.htm IDEA: XBRL DOCUMENT

1. General Information (Details Narrative)	12 Months Ended
1. General Information (Details Narrative)	Dec. 31, 2021
1. General Information
Incorporation date	October 30, 2006

XML 25 R16.htm IDEA: XBRL DOCUMENT

4. Amount Due to a Related Party (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
4. Amount Due to a Related Party
Amount due to a related party	$ 349,387	$ 316,458

- Definition

Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(C))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(B))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(k)(1))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756

+ Details

XML 26 R17.htm IDEA: XBRL DOCUMENT

5. Preferred Stock/Common Stock (Details Narrative) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
5. Preferred Stock/Common Stock
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	250,000,000	250,000,000
Voting rights shares	1,000
Preferred stock convertible into shares	1,000

XML 27 R18.htm IDEA: XBRL DOCUMENT

6 Income Tax (Details) - USD ($)	12 Months Ended
6 Income Tax (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Federal income tax benefit attributable to:
Net loss	$ (7,000)	$ (8,500)
Change in tax estimates	0	10,000
Less: valuation allowance	7,000	1,700
Net provision for Federal income taxes	$ 0	$ 0

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

XML 28 R19.htm IDEA: XBRL DOCUMENT

6 Income Tax (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred tax asset attributable to:
Net operating loss carryforwards	$ 238,000	$ 231,000
Less: valuation allowance	(238,000)	(231,000)
Net deferred tax asset	$ 0	$ 0

XML 29 R20.htm IDEA: XBRL DOCUMENT

6. Income Tax (Details Narrative) - USD ($)	12 Months Ended
6. Income Tax (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2011
6. Income Tax
Net operating loss carry forwards	$ 943,000		$ 213,844
Description of asset and allowances	The deferred tax asset and valuation allowance were reduced by approximately $1,000 to reflect the change in the federal tax rate from 34% to 21%.
Cumulative tax effect rate	21.00%	21.00%

XML 30 gplb_10k_htm.xml IDEA: XBRL DOCUMENT 0001392449 2021-01-01 2021-12-31 0001392449 2011-12-31 0001392449 2022-12-31 0001392449 2022-01-01 2022-12-31 0001392449 us-gaap:RetainedEarningsMember 2021-12-31 0001392449 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001392449 us-gaap:CommonStockMember 2021-12-31 0001392449 us-gaap:PreferredStockMember 2021-12-31 0001392449 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001392449 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001392449 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001392449 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001392449 us-gaap:RetainedEarningsMember 2020-12-31 0001392449 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001392449 us-gaap:CommonStockMember 2020-12-31 0001392449 us-gaap:PreferredStockMember 2020-12-31 0001392449 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001392449 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001392449 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001392449 us-gaap:PreferredStockMember 2020-01-01 2020-12-31 0001392449 2019-12-31 0001392449 us-gaap:RetainedEarningsMember 2019-12-31 0001392449 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001392449 us-gaap:CommonStockMember 2019-12-31 0001392449 us-gaap:PreferredStockMember 2019-12-31 0001392449 2020-01-01 2020-12-31 0001392449 2020-12-31 0001392449 2021-12-31 0001392449 2022-03-14 0001392449 2021-06-30 iso4217:USD shares iso4217:USD shares pure 0001392449 false --12-31 false 2021-12-31 FY 2021

0.001

10000000

0.001

20006402

-0.00

10-K true false 000-52622 GREEN PLANET BIOENGINEERING CO., LTD. DE 37-1532842 20807 Biscayne Blvd. Suite 203 Aventura FL 33180 786 279-2900 No No Yes Yes Non-accelerated Filer true true 65655 20006402 287 Liggett & Webb, P.A. Boynton Beach, Florida

349387

316458

349387

316458

0.001

10000000

0.001

250000000

20006402

20006

609614

-979007

-946078

-349387

-316458

32929

33599

-32929

-33599

-32929

-33599

20006402

-32929

-33599

-214

-32929

-33813

32929

33813

32929

33813

20006402

20006

609614

-912479

-282859

-33599

20006402

20006

609614

-946078

-316458

-32929

20006402

20006

609614

-979007

-349387

1. General Information Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and the name was changed to Green Planet Bioengineering Co., Ltd. (“Company”) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries (“Elevated Throne”) and operated the business in the agritech sector in the People’s Republic of China. The Company divested Elevated Throne to One Bio, Corp. (“ONE”) on April 14, 2010. In March 2012, Global Funds Holdings Corp. (“Global Funds”) an Ontario, Canada corporation became a majority stockholder of the Company. The Company operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation. The Company’s activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

October 30, 2006

2. Summary of Significant Accounting Policies Basis of PresentationThe financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). Use of EstimatesThe preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported. Actual results could differ from those estimates. Significant items that require estimates were accruals of liabilities. Cash and Cash EquivalentsCash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits. Income TaxesThe Company accounts for income taxes in accordance with FASB ASC Topic 740 “Income Taxes” under which deferred tax assets and liabilities are determined based on temporary differences between accounting and tax bases of assets and liabilities and net operating loss and credit carry forwards, using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. A provision for income tax expense is recognized for income taxes payable for the current period, plus the net changes in deferred tax amounts. Any interest and penalties are expensed in the year that the Notice of Assessment is received. The Company’s practice is to recognize interest and/or penalties related to income tax matters as interest expense. Loss Per ShareEarnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures. Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive. Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share. As of December 31, 2021 and 2020 the Company does not have any common share equivalents outstanding.Fair Value MeasurementsFASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investments measured and reported at fair value are classified and disclosed in one of the following hierarchy: <table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;">Level 1 -</td><td style="vertical-align:top;">Quoted prices are available in active markets for identical investments as of the period reporting date.</td></tr><tr style="height:15px"><td> </td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Level 2 -</td><td style="vertical-align:top;">Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.</td></tr><tr style="height:15px"><td> </td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Level 3 -</td><td style="vertical-align:top;">Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.</td></tr></tbody></table> Recent Changes in Accounting StandardsIn June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including the interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The adoption of this ASU did not have a material impact on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported. Actual results could differ from those estimates. Significant items that require estimates were accruals of liabilities.

Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.

The Company accounts for income taxes in accordance with FASB ASC Topic 740 “Income Taxes” under which deferred tax assets and liabilities are determined based on temporary differences between accounting and tax bases of assets and liabilities and net operating loss and credit carry forwards, using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. A provision for income tax expense is recognized for income taxes payable for the current period, plus the net changes in deferred tax amounts. Any interest and penalties are expensed in the year that the Notice of Assessment is received. The Company’s practice is to recognize interest and/or penalties related to income tax matters as interest expense.

Earnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures. Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive. Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share. As of December 31, 2021 and 2020 the Company does not have any common share equivalents outstanding.

FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investments measured and reported at fair value are classified and disclosed in one of the following hierarchy: <table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;">Level 1 -</td><td style="vertical-align:top;">Quoted prices are available in active markets for identical investments as of the period reporting date.</td></tr><tr style="height:15px"><td> </td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Level 2 -</td><td style="vertical-align:top;">Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.</td></tr><tr style="height:15px"><td> </td><td> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Level 3 -</td><td style="vertical-align:top;">Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.</td></tr></tbody></table>

In June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including the interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. The adoption of this ASU did not have a material impact on the Company’s financial statements. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

3. Going Concern The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from a related party. This gives rise to substantial doubt about the Company’s ability to continue as a going concern.

4. Amount Due to a Related party The Company relies on a related party to advance funds to fund its operating expenses. As of December 31, 2021 and 2020, the amounts advanced of $349,387 and $316,458 respectively are interest-free, unsecured and are repayable upon demand. In addition, the Chief Executive Officer, Chief Financial Officer and Director of the Company is also a director of the related party.

349387

316458

5. Preferred Stock/Common Stock Series A preferred stockThe Company is authorized under its Articles of Incorporation to issue 10,000,000 shares of Series A preferred stock with a par value of $0.001 per share. Each share of the Company’s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company’s common stock. The preferred stock is non-participating and carries no dividend. The Company does not have any issued shares of the preferred stock as of December 31, 2021 and 2020. Common StockThe Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001 per share. During the year ended December 31, 2021 and 2020, the Company did not issue any shares of common stock or warrants.

10000000

0.001

1000

250000000

0.001

6. Income Tax As of December 31, 2021, the Company had net operating loss carry forwards of approximately $943,000 that may be available to reduce future years’ taxable income through 2037. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards. The deferred tax asset and valuation allowance were reduced by approximately $1,000 to reflect the change in the federal tax rate from 34% to 21%. The provision for Federal income tax consists of the following for the years ended December 31, 2021 and December 31, 2020: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Federal income tax benefit attributable to:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net loss </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8,500</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Change in tax estimates</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Less: valuation allowance </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,700</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net provision for Federal income taxes</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table> The cumulative tax effect at the expected rate of 21% for 2021 and 21% for 2020 of significant items comprising our net deferred tax amount is as follows as of December 31, 2021 and December 31, 2020: <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Deferred tax asset attributable to:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net operating loss carryover</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">238,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">231,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Less: valuation allowance</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(238,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(231,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Net deferred tax asset</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table> Due to the change in ownership in March 2012, the net operating loss carry forwards as of December 31, 2011 of $213,844 may be subject to limitations in accordance with Sec 382 of the provisions of the Tax Reform Act of 1986 for Federal income tax purposes. Tax return for the years ended December 31, 2021, 2020 and 2019 remain open to and it by Federal and State Tax Authorities.

943000

The deferred tax asset and valuation allowance were reduced by approximately $1,000 to reflect the change in the federal tax rate from 34% to 21%.

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Federal income tax benefit attributable to:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net loss </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(7,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(8,500</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Change in tax estimates</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Less: valuation allowance </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">7,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,700</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net provision for Federal income taxes</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table>

-7000

-8500

10000

7000

1700

0.21 0.21

<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2021</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td><td style="white-space: nowrap;"> </td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:center;">December 31, 2020</td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"> </td></tr><tr style="height:15px"><td style="vertical-align:top;">Deferred tax asset attributable to:</td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td class="ffcell" colspan="2" style="width:9%;"> </td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;">Net operating loss carryover</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">238,000</td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">231,000</td><td style="width:1%;white-space: nowrap;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Less: valuation allowance</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(238,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"> </td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(231,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td><td> </td><td> </td><td class="ffcell"> </td><td> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;">Net deferred tax asset</td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td><td style="width:1%;white-space: nowrap;"> </td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"> </td></tr></tbody></table>

238000

231000

238000

231000

213844

EXCEL 31 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 33 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 34 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 30 181 1 false 4 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://greenplanetbio.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Balance Sheets Sheet http://greenplanetbio.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 000003 - Statement - Balance Sheets (Parenthetical) Sheet http://greenplanetbio.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Statements of Operations Sheet http://greenplanetbio.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 000005 - Statement - Statements of Changes in Stockholders' Deficit Sheet http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit Statements of Changes in Stockholders' Deficit Statements 5 false false R6.htm 000006 - Statement - Statements of Cash Flows Sheet http://greenplanetbio.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 6 false false R7.htm 000007 - Disclosure - 1. General Information Sheet http://greenplanetbio.com/role/GeneralInformation 1. General Information Notes 7 false false R8.htm 000008 - Disclosure - 2. Summary of Significant Accounting Policies Sheet http://greenplanetbio.com/role/SummaryOfSignificantAccountingPolicies 2. Summary of Significant Accounting Policies Notes 8 false false R9.htm 000009 - Disclosure - 3. Going Concern Sheet http://greenplanetbio.com/role/GoingConcern 3. Going Concern Notes 9 false false R10.htm 000010 - Disclosure - 4. Amount Due to a Related Party Sheet http://greenplanetbio.com/role/AmountDueToARelatedParty 4. Amount Due to a Related Party Notes 10 false false R11.htm 000011 - Disclosure - 5. Preferred Stock/Common Stock Sheet http://greenplanetbio.com/role/PreferredStockCommonStock 5. Preferred Stock/Common Stock Notes 11 false false R12.htm 000012 - Disclosure - 6. Income Tax Sheet http://greenplanetbio.com/role/IncomeTax 6. Income Tax Notes 12 false false R13.htm 000013 - Disclosure - 2 Summary of significant accounting policies (Policies) Sheet http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2 Summary of significant accounting policies (Policies) Policies http://greenplanetbio.com/role/SummaryOfSignificantAccountingPolicies 13 false false R14.htm 000014 - Disclosure - 6. Income Tax (Tables) Sheet http://greenplanetbio.com/role/IncomeTaxTables 6. Income Tax (Tables) Tables http://greenplanetbio.com/role/IncomeTax 14 false false R15.htm 000015 - Disclosure - 1. General Information (Details Narrative) Sheet http://greenplanetbio.com/role/GeneralInformationDetailsNarrative 1. General Information (Details Narrative) Details http://greenplanetbio.com/role/GeneralInformation 15 false false R16.htm 000016 - Disclosure - 4. Amount Due to a Related Party (Details Narrative) Sheet http://greenplanetbio.com/role/AmountDueToARelatedPartyDetailsNarrative 4. Amount Due to a Related Party (Details Narrative) Details http://greenplanetbio.com/role/AmountDueToARelatedParty 16 false false R17.htm 000017 - Disclosure - 5. Preferred Stock/Common Stock (Details Narrative) Sheet http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative 5. Preferred Stock/Common Stock (Details Narrative) Details http://greenplanetbio.com/role/PreferredStockCommonStock 17 false false R18.htm 000018 - Disclosure - 6 Income Tax (Details) Sheet http://greenplanetbio.com/role/IncomeTaxDetails 6 Income Tax (Details) Details 18 false false R19.htm 000019 - Disclosure - 6 Income Tax (Details 1) Sheet http://greenplanetbio.com/role/IncomeTaxDetails1 6 Income Tax (Details 1) Details 19 false false R20.htm 000020 - Disclosure - 6. Income Tax (Details Narrative) Sheet http://greenplanetbio.com/role/IncomeTaxDetailsNarrative 6. Income Tax (Details Narrative) Details http://greenplanetbio.com/role/IncomeTaxTables 20 false false All Reports Book All Reports gplb_10k.htm gplb-20211231.xsd gplb-20211231_cal.xml gplb-20211231_def.xml gplb-20211231_lab.xml gplb-20211231_pre.xml gplb_ex311.htm gplb_ex312.htm gplb_ex32.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 37 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gplb_10k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 30, "dts": { "calculationLink": { "local": [ "gplb-20211231_cal.xml" ] }, "definitionLink": { "local": [ "gplb-20211231_def.xml" ] }, "inline": { "local": [ "gplb_10k.htm" ] }, "labelLink": { "local": [ "gplb-20211231_lab.xml" ] }, "presentationLink": { "local": [ "gplb-20211231_pre.xml" ] }, "schema": { "local": [ "gplb-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" ] } }, "elementCount": 125, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 12, "http://xbrl.sec.gov/dei/2021q4": 7, "total": 19 }, "keyCustom": 4, "keyStandard": 177, "memberCustom": 0, "memberStandard": 4, "nsprefix": "gplb", "nsuri": "http://greenplanetbio.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://greenplanetbio.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - 4. Amount Due to a Related Party", "role": "http://greenplanetbio.com/role/AmountDueToARelatedParty", "shortName": "4. Amount Due to a Related Party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - 5. Preferred Stock/Common Stock", "role": "http://greenplanetbio.com/role/PreferredStockCommonStock", "shortName": "5. Preferred Stock/Common Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - 6. Income Tax", "role": "http://greenplanetbio.com/role/IncomeTax", "shortName": "6. Income Tax", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - 2 Summary of significant accounting policies (Policies)", "role": "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "2 Summary of significant accounting policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - 6. Income Tax (Tables)", "role": "http://greenplanetbio.com/role/IncomeTaxTables", "shortName": "6. Income Tax (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "gplb:IncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - 1. General Information (Details Narrative)", "role": "http://greenplanetbio.com/role/GeneralInformationDetailsNarrative", "shortName": "1. General Information (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "gplb:IncorporationDateOfIncorporation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - 4. Amount Due to a Related Party (Details Narrative)", "role": "http://greenplanetbio.com/role/AmountDueToARelatedPartyDetailsNarrative", "shortName": "4. Amount Due to a Related Party (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R17": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - 5. Preferred Stock/Common Stock (Details Narrative)", "role": "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative", "shortName": "5. Preferred Stock/Common Stock (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "gplb:VotingRightsShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - 6 Income Tax (Details)", "role": "http://greenplanetbio.com/role/IncomeTaxDetails", "shortName": "6 Income Tax (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - 6 Income Tax (Details 1)", "role": "http://greenplanetbio.com/role/IncomeTaxDetails1", "shortName": "6 Income Tax (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - Balance Sheets", "role": "http://greenplanetbio.com/role/BalanceSheets", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - 6. Income Tax (Details Narrative)", "role": "http://greenplanetbio.com/role/IncomeTaxDetailsNarrative", "shortName": "6. Income Tax (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - Balance Sheets (Parenthetical)", "role": "http://greenplanetbio.com/role/BalanceSheetsParenthetical", "shortName": "Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - Statements of Operations", "role": "http://greenplanetbio.com/role/StatementsOfOperations", "shortName": "Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - Statements of Changes in Stockholders' Deficit", "role": "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit", "shortName": "Statements of Changes in Stockholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - Statements of Cash Flows", "role": "http://greenplanetbio.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - 1. General Information", "role": "http://greenplanetbio.com/role/GeneralInformation", "shortName": "1. General Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - 2. Summary of Significant Accounting Policies", "role": "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "2. Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - 3. Going Concern", "role": "http://greenplanetbio.com/role/GoingConcern", "shortName": "3. Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gplb_10k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 4, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r176", "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm Id" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r176", "r177", "r178" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r176", "r177", "r178" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r176", "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r181" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://greenplanetbio.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "gplb_CumulativeTaxEffectRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cumulative tax effect rate" } } }, "localname": "CumulativeTaxEffectRate", "nsuri": "http://greenplanetbio.com/20211231", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "percentItemType" }, "gplb_DescriptionOfAseetAndAllowances": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of asset and allowances" } } }, "localname": "DescriptionOfAseetAndAllowances", "nsuri": "http://greenplanetbio.com/20211231", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "stringItemType" }, "gplb_IncorporationDateOfIncorporation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incorporation date" } } }, "localname": "IncorporationDateOfIncorporation", "nsuri": "http://greenplanetbio.com/20211231", "presentation": [ "http://greenplanetbio.com/role/GeneralInformationDetailsNarrative" ], "xbrltype": "stringItemType" }, "gplb_VotingRightsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Voting rights shares" } } }, "localname": "VotingRightsShares", "nsuri": "http://greenplanetbio.com/20211231", "presentation": [ "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2. Summary of Significant Accounting Policies" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r11" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r45", "r46", "r47", "r110", "r111", "r112", "r145" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r20", "r39", "r76", "r78", "r79", "r80", "r82", "r83", "r84", "r85", "r86", "r87", "r89", "r90", "r140", "r142", "r147", "r160", "r162" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "TOTAL CURRENT ASSETS" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "verboseLabel": "2. Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r16", "r35" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents - end of year", "periodStartLabel": "Cash and cash equivalents - beginning of year" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets", "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r7", "r36" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r30", "r148" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "totalLabel": "Net decrease in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r45", "r46", "r145" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical", "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, authorized", "verboseLabel": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical", "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r105" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r10", "r162" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock: par value of $0.001 per share Issued and outstanding: 20,006,402 shares at December 31, 2021 and December 31, 2020" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r8", "r9", "r101", "r106", "r107" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Preferred stock convertible into shares" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r123" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax asset attributable to:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r127", "r128" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "[Deferred Tax Assets, Valuation Allowance]", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r17", "r43", "r81", "r83", "r84", "r88", "r89", "r90", "r157" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Amount due to a related party", "verboseLabel": "Amount due to a related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/AmountDueToARelatedPartyDetailsNarrative", "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "-Basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r59", "r60" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "5. Preferred Stock/Common Stock" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r24", "r25", "r26", "r45", "r46", "r47", "r49", "r54", "r56", "r61", "r77", "r105", "r108", "r110", "r111", "r112", "r130", "r131", "r145", "r149", "r150", "r151", "r152", "r153", "r154", "r170", "r171", "r172", "r182" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal income tax benefit attributable to:" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r28" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "[General and Administrative Expense]", "negatedLabel": "Administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r40", "r134" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "[Income (Loss) from Continuing Operations before Income Taxes, Domestic]", "totalLabel": "Loss before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "6. Income Tax" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r41", "r119", "r120", "r125", "r132", "r135", "r137", "r138", "r139" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "6. Income Tax" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTax" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r42", "r55", "r56", "r69", "r117", "r133", "r136", "r169" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Provision for income taxes", "verboseLabel": "Net provision for Federal income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails", "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r23", "r115", "r116", "r120", "r121", "r124", "r129" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Less: valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r114", "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Change in tax estimates" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r118" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "[Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount]", "verboseLabel": "Net loss" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r33" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r33" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "[Increase (Decrease) in Due to Related Parties]", "verboseLabel": "Amount due to a related party" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r29", "r31", "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r15", "r39", "r76", "r147", "r162", "r164", "r167" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r18", "r39", "r76", "r78", "r79", "r80", "r83", "r84", "r85", "r86", "r87", "r89", "r90", "r141", "r142", "r143", "r147", "r160", "r161", "r162" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "TOTAL CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r30" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Net cash flows provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r30", "r32", "r34" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Net cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r21", "r22", "r26", "r27", "r34", "r39", "r48", "r50", "r51", "r52", "r53", "r55", "r56", "r57", "r70", "r71", "r72", "r73", "r74", "r76", "r78", "r79", "r80", "r83", "r84", "r85", "r86", "r87", "r89", "r90", "r146", "r147", "r165", "r168" ], "calculation": { "http://greenplanetbio.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://greenplanetbio.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows", "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit", "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Changes in Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net operating loss carry forwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "1. General Information" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r3", "r144" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "verboseLabel": "1. General Information" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/GeneralInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r9", "r91" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical", "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, authorized", "verboseLabel": "Preferred stock, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical", "http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r9", "r91" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r9", "r162" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock: par value of $0.001 per share Issued and outstanding:None at December 31, 2021 and December 31, 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "4. Amount Due to a Related Party" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r155", "r156", "r157", "r158", "r159" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "4. Amount Due to a Related Party" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/AmountDueToARelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r12", "r108", "r113", "r162", "r166", "r173", "r174" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r45", "r46", "r47", "r49", "r54", "r56", "r77", "r110", "r111", "r112", "r130", "r131", "r145", "r170", "r172" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "verboseLabel": "Provision for income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Deferred tax assets" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r105" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r19", "r24", "r25", "r26", "r45", "r46", "r47", "r49", "r54", "r56", "r61", "r77", "r105", "r108", "r110", "r111", "r112", "r130", "r131", "r145", "r149", "r150", "r151", "r152", "r153", "r154", "r170", "r171", "r172", "r182" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statements of Changes in Stockholders' Deficit" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r45", "r46", "r47", "r61", "r163" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r10", "r13", "r14", "r39", "r75", "r76", "r147", "r162" ], "calculation": { "http://greenplanetbio.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "TOTAL STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets", "http://greenplanetbio.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' DEFICIT", "verboseLabel": "STOCKHOLDERS' DEFICIT" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/BalanceSheets", "http://greenplanetbio.com/role/BalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r38", "r92", "r93", "r94", "r95", "r96", "r97", "r98", "r99", "r100", "r102", "r103", "r104", "r108", "r109" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "5. Preferred Stock/Common Stock" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/PreferredStockCommonStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]", "verboseLabel": "3. Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures for cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r62", "r63", "r64", "r65", "r66", "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "[Weighted Average Number of Shares Outstanding, Basic and Diluted]", "verboseLabel": "-Basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://greenplanetbio.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r139": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r159": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r175": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r176": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r177": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r178": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r179": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r181": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" } }, "version": "2.1" } ZIP 38 0001654954-22-003076-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-22-003076-xbrl.zip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